Search

everythinglearnresearchcommunity

for

Search:↓

A specific gene variation is linked to a higher risk of polycystic ovary syndrome in Caucasian women.

Anti-androgens can help manage some PCOS symptoms better than metformin but are not more effective than placebos or birth control pills for other symptoms.

Certain changes in the VEGF gene can increase or decrease the risk of polycystic ovary syndrome.

The link between physical signs of high male hormones and hormone levels in women with PCOS changes with age.

Magnesium supplements improved quality of life for women with polycystic ovary syndrome, but didn't help with acne, hair loss, or abnormal bleeding.

Microbial imbalances in hair follicles may contribute to hair loss, especially in women.

Future treatments for androgenic alopecia may focus on reactivating hair follicle stem cells and improving drug delivery.

SPIOMET therapy may be a promising alternative to oral contraceptives for treating adolescent PCOS.

Personalized treatments for hair loss are becoming more effective by using genetic information.

STK11 gene polymorphism does not predict metformin response in PCOS.

Too much prolactin can cause menstrual problems, infertility, and sexual issues in women.

Hormone levels studied are not linked to PCOS.

Certain brain hormones and chemicals are linked to the development of Polycystic Ovary Syndrome.

High doses of nandrolone decanoate disrupt ovarian hormones and receptors in rats, with recovery only at lower doses and longer recovery times.

Certain blood metabolites are linked to female pattern hair loss, with some increasing risk and others offering protection.

Male-pattern hair loss is largely influenced by genetics, with key genes identified.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Obesity is linked to various skin disorders, which can help with early diagnosis and prevention of long-term health issues.

11α-Hydroxyprogesterone is changed into different substances by certain enzymes and may play a role in prostate cancer.

The -866G/A polymorphism in the UCP2 gene is not linked to polycystic ovary syndrome.

Combining genetic and physical data improves diagnosis and treatment for early-onset monogenic diabetes.

The document concludes that Syndromes of Severe Insulin Resistance are rare disorders with limited treatment options.

Ayurvedic plants may help treat PCOD by affecting hormones and ovarian health.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

The document concludes that patient outcomes for Congenital Adrenal Hyperplasia are often not ideal because of poor management and a need for better diagnosis and treatment methods.

Excess maternal androgens can cause heart problems in offspring.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

Obesity negatively affects the endometrium, leading to higher miscarriage risk and impaired cell function.

Ferulic acid may help hair grow by activating certain receptors in cells.